Cystic fibrosis airway inflammation enables elexacaftor/tezacaftor/ivacaftor-mediated rescue of N1303K CFTR mutation von Gentzsch, Martina, Baker, Brooke, Cholon, Deborah M, Kam, Charissa W, McKinzie, Cameron J, Despotes, Katherine A, Boyles, Susan E, Quinney, Nancy L, Esther, Jr, Charles R, Ribeiro, Carla M P

Volltext

Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy von McKinzie, Cameron J., Duehlmeyer, Stephanie R., Kam, Charissa W., Safirstein, Julie

Volltext

Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis von De Vuyst, Richard C., Bennard, Erin, Kam, Charissa W., McKinzie, Cameron J., Esther, Charles R.

Volltext

Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor von De Vuyst, Richard, Kam, Charissa W., McKinzie, Cameron J., Esther, Charles R.

Volltext

Opportunities and challenges of pharmacotherapy for pulmonary arterial hypertension in children von Kam, Charissa W., Ruiz, Fadel E.

Volltext

Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series von Kam, Charissa W, McKinzie, Cameron J, Omecene, Nicole E, Peters, Stacy, Pettit, Rebecca S, Poisson, Margaret O, Witte, Jennifer

Volltext

Pharmacist‐administered audiology screening for pediatric cystic fibrosis patients exposed to high‐dose aminoglycosides: A pilot study von McKinzie, Cameron J., Kam, Charissa W., Parry, Rachel, Darby, Marcus, Tak, Casey R.

Volltext

Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis von McKinzie, Cameron J., Kam, Charissa W., Jones, Morgan C., Gifford, Laura B., Loughlin, Ceila E., Noah, Terry L., Shenoy, Vivek K., Dellon, Elisabeth P.

Volltext

Novel therapies for treatment of resistant and refractory nontuberculous mycobacterial infections in patients with cystic fibrosis von Laudone, Thomas W., Garner, Lauren, Kam, Charissa W., Esther, Charles R., McKinzie, Cameron J.

Volltext

Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis von Stephenson, Kimberly G, Lingle, Abby J, Baumberger, Kelly A, Dellon, Elisabeth P, Esther, Jr, Charles R, Meier, Ellen M, Oermann, Christopher M, Shenoy, Vivek K, Smith, Natalie R, Wimmer, Nicole S, Duehlmeyer, Stephanie R, Kam, Charissa W, McKinzie, Cameron J, Poisson, Margaret O, Elson, E Claire

Volltext